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ABSTRACT
The herpes simplex virus type 1 (HSV-1) Immediate-
Early (IE) polypeptide Vmw175 Is essential for the
activation of transcription from viral early and late
promoters. Vmw175 also reduces the activity of its own
(IE-3) promoter In transfectlon assays. Both
transactivatlon and repression mediated by Vmw175
require the integrity of a conserved domain of the
polypeptide which has been shown to bind to specific
DNA sequences. We have investigated the DNA
sequence requirements for Vmw175 binding using a
randomly mutated target. The results indicate that the
binding site covers a region of 13 nucleotldes divided
into proximal and distal parts which are consistent with
the consensus ATCGTNNNNNYSG. We have also
expressed several different constructs encompassing
the DNA binding domain of Vmw175 in bacteria, and
obtained preparations of greater than 90% purity. The
DNA binding domain is a dimer in solution, and binds
DNA with a specificity similar to that of the Intact
protein, although the smallest DNA binding competent
protein has a slightly reduced specificity.
INTRODUCTION
Herpes simplex virus type 1 (HSV-1) encodes at least 72 distinct
genes in a genome of approximately 150kb (1). These genes can
be divided into three differentially regulated groups (Immediate-
Early (IE), early and late) based on the time course of their
expression and whether they can be transcribed in the absence
of viral protein synthesis or viral DNA replication (for reviews
see references 2—4). The IE genes are transcribed first, and the
function of at least some of the IE polypeptides is required for
the normal expression of the later classes of genes. Of the five
IE gene products, Vmwl75 (expressed from gene IE-3) is perhaps
the most important since its inactivation results in failure to
transcribe early or late genes and an apparent over-expression
of the IE genes (5,6). Thus Vmwl75 is directly or indirectly
required for the normal regulation of all odier HSV-1 genes.
The properties of Vmwl75 have been investigated in some
detail. It is a phosphorylated nuclear protein of 1298 predicted
residues which binds to DNA in crude cell extracts and is
associated with chromatin (7—9). Vmwl75 has been purified as
a homodimer (10,11) and has been shown to bind specifically
to selected DNA sequences (12—23). The conclusion from these
studies is that many (but not all) of the sites bound by Vmwl75
include the motif ATCGTC, that this sequence alone is not
sufficient for DNA binding, and that a further sequence further
3' is also required. An extended binding consensus of RTCGT-
CNNYNYSG has recently been described (24). However, the
contributions to binding strength of each base within this
consensus has not been rigorously examined. One aim of the
present study was to conduct a thorough mutagenic analysis of
a single binding site in order to determine the relative importance
of both conserved and non-conserved bases within and outside
the consensus.
The DNA binding domain of Vmwl75 has been defined by
mutagenic studies (25—28), by its protease resistance (29) and
by its expression as a fusion protein in bacteria (23,30). It consists
of the entire conserved region 2 of the polypeptide (31), which
is found in all the related proteins encoded by members of the
sub-familiy alphaherpesviridae (32—34), and also the distal
portion of die less conserved region 1. We have previously
reported the expression in bacteria of non-fusion proteins
comprising die DNA binding domain of Vmwl75 (23). In this
report we describe the purification to apparent homogeneity of
die bacterially expressed polypeptide. The bacterial proteins
showed similar DNA binding specificity to drat of Vmwl75
expressed in virus-infected cells, although there was some
relaxation of specificity using the smallest binding-competent
protein studied.
Vmwl75 expressed in infected cells can be purified in solution
as a dimer or higher order oligomers (10). The intact protein
also binds DNA as a dimer (17,35). In this study we found by
physical analysis that the isolated DNA binding domain is also
a dimer, which raises the question whether, like many other DNA
binding proteins, dimerisation of Vmwl75 is important for DNA
binding. The role of DNA binding by Vmwl75 in regulating
transcription is discussed.
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MATERIALS AND METHODS
Plasmids, bacteria, cells and viruses
Plasmid pl75 and its insertion mutants pI9, pHO, pll 1 and pI12
have been described previously (26). Plasmid p585.4, a T7
expression vector derived from pET-8c (36) with HindlD and
BamHI sites present after the Ncol site at the initiation of
translation, was kindly provided by Dr. C.M.Preston. All
plasmids were constructed and maintained in E. coli strain
HB101. For expression experiments, the plasmids were
transformed into E. coli strain BL21 (DE3) pLysS (36).
Bacteriophage M13mpl8 was used as the vector for
oligonucleotide directed mutagenesis. The host bacterium JM101
was used for the growth and maintenance of all M13
bacteriophage.
HSV-1 strain 17 syn+ was grown and titrated in BHK C13
cells which were propagated in Glasgow modified Eagles medium
(GMEM) supplemented with 10% new born calf serum, 10%
tryptose phosphate broth and penicillin (lOOjt/ml) and
streptomycin (lOO/tg/ml). Crude extracts containing Vmwl75
were prepared from HSV-1 infected HeLa cells (Flow
Laboratories) grown in GMEM with 10% foetal calf serum and
penicillin and streptomycin as above.
Construction of T7 expression plasmids and crude extract
preparation of induced bacteria
The construction of the expression plasmids pT7I9X, pT7I10X
and pT7Ill have been described previously (23). The T7
expression plasmids were transformed into E. coli host BL21
(DE3) pLysS and maintained as glycerol stocks. Bacteria were
grown, induced with IPTG, harvested in 0.01 volumes of lOmM
Tris-HCl pH 8.0, lmM EDTA, lmM PMSF, 0. lmM DTT and
crude extracts prepared as described before (23).
Purification of protein I10X
Bacteria were grown, induced and harvested as above. After
thawing, the bacteria were lysed and treated with DNase I and
RNase (final concentrations 20/tg/ml and 100/tg/ml respectively)
on ice for several minutes until the mixture became less viscous.
Then NaCl and polymin P were added to final concentrations
of 0.5M and 0.2% respectively, and insoluble material was
pelleted by centrifugation at 15,000rpm for 30 minutes in the
Sorvall SS34 rotor. The clarified supernatant was brought to 25%
saturation with ammonium sulphate and precipitated proteins
dissolved in 50mM Hepes pH 7.5, 50mM NaCl, lmM PMSF,
O.lmM DTT, 0.1% CHAPS and then dialysed against 50mM
Bis-Tris pH 6.6, 50mM NaCl, lmM PMSF, O.lmM DTT,
0.01% CHAPS and stored at -20°C. The volume of extract
obtained from a 1L culture was 3ml.
The I10X DNA binding domain peptide of Vmwl75 was
purified from the initial extract by two steps of Pharmacia FPLC
ion exchange chromatography. The first step used a Mono Q
column equilibrated in the same buffer as the final crude extract.
15ml of extract was loaded onto an 8ml column and eluted with
a 50mM to 1M NaCl gradient in the Bis-Tris buffer. Fractions
containing the Vmwl75 peptide were identified by SDS-
polyacrylamide electrophoresis; the II OX protein eluted mainly
in the flow-dirough. Pooled fractions were dialysed against 50mM
Hepes pH 7.5, 50mM NaCl, lmM PMSF, O.lmM DTT, 0.01%
CHAPS and then loaded onto a lml Mono S column equilibrated
in the same buffer. A salt gradient was applied, which eluted
the I10X protein as a sharp peak at 0.29M NaCl. The purification
illustrated in this paper yielded about 0.2mg purified I10X per
litre of culture (higher yields have been obtained in more recent
experiments). At least 20% of this material was able to bind to
DNA in gel retardation experiments (data not shown).
Preparation of probes for gel retardation experiments
Some experiments used end-labelled isolated restriction fragment
probes which contained well defined Vmwl75 binding sites. The
IE-3 probe (19), including the cap-site region of gene IE-3, was
isolated as a BamHI-EcoRI fragment (encompassing bases +27
to -108 of the IE-3 promoter) from plasmid pIE3CAT (26) by
cutting with BamHI, labelling the end with Klenow and a 32P-
dGTP, and then cutting with EcoRI. The labelled fragment was
separated on an 8% non-denaturing polyacrylamide gel, located
by autoradiography, passively eluted from the gel and ethanol
precipitated. For some experiments a 180bp Aval fragment
(spanning nucleotides -129 to +56 of the IE-1 promoter region;
the cap site is at position +1 and the A of the ATCGTC consensus
is at position -68) which contains another strong Vmwl75
binding site (16) was prepared from plasmid pIElCAT (37).
Comparative gel retardation analysis of binding sites with single
point mutations used probes prepared by the prime-cut method
(38). Single-stranded M13 templates derived from M13IE3EB
(see below) were annealed with the M13 universal primer and
then incubated with Klenow polymerase and 5/tCi of a 32P-
dATP in a mix containing lOmM Tris-HCl pH 8.0, lOmM
MgCl2 and dCTP, dGTP and dTTP (each at 0.05mM) and
0.6uM dATP. After incubation at 37°C for 30 min all four
dNTPs were added to increase their concentration by a further
O.lmM and incubation continued for a further 10 min. After
heating at 70°C for 10 min, suitable restriction enzyme buffer
and EcoRI and BamHI were added and the digestion incubated
at 37°C for 90 min. Labelled probe fragments were separated
on acrylamide gels and eluted as above. Further purification
omitted the G50 column step. Radioactivity in the final
preparations was measured by Cerenkov counting; probes were
dissolved in volumes of water so as to give equal radioactivity
concentrations. Since the specific activity of the radioactive dATP
was the same for each probe prepared at the same time, this
results in equal chemical probe concentrations. In all series of
probe preparations, a wild-type control was prepared in an
identical manner.
Gel retardation assays
Suitable amounts of bacterial or nuclear extracts were mixed with
radiolabelled probes on ice in a buffer containing lOmM Tris-
HCl pH 8.0, lmM EDTA, lOOmM NaCl, lug polydl/polydC
and 0.1% NP40. Incubations included O.lng of end-labelled
fragment probes or equal quantities of freshly prepared prime-
cut probes. After incubation for 20 minutes, the mixtures were
applied to a non-denaturing 4% polyacrylamide gel with
0.5 XTBE running buffer and run at 200V at 4°C for 2 to 3 hours.
DNA-protein complexes and unbound probe were detected by
autoradiography of the dried gel. Where appropriate, the extent
of binding was determined by densitometric scanning of suitably
exposed autoradiographs followed by calculation of the
percentage of total probe bound. Some extracts containing the
I10X protein were very active in DNA binding reactions; in these
cases dilutions of the extract were used so that the proportion
of the wild-type probe complexed was not more than 50%.
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Oligonucleotide directed mutagenesis
The oligonucleotide 5' GCCGCGCTCCGTGTGGACGATCG-
GGGCGTCCTCGGG 3' was synthesised using vials of stock
precursors which had been contaminated with about 1.1% of each
of the other precursors. The product was purified by gel
electrophoresis, phosphorylated and used in a mutagenesis
reaction using the Amersharn M13 mutagenesis kit. The template
was M13IE3EB, which has the IE-3 EcoRI-BamHI capsite region
(see above) cloned into M13mpl8. After mutagenesis, the
mixture was transfected into JM101 and plaques picked for
screening by DNA sequence analysis. Examination of 400 plaques
resulted in the isolation of a cohort of mutants including at least
one, and frequently more than one, of the possible single point
mutations at each of the nucleotides in the vicinity of the Vmwl75
binding site. In addition, a number of useful double mutants were
isolated along with a number of single base deletions. In all, about
100 useful mutations were found in the 400 plaques examined.
Gel filtration chromatography and glycerol gradient
centrifugation
The true molecular weight of purified II OX protein was
determined by gel filtration and glycerol gradient analysis. A
Pharmacia FPLC Superose 12 column was equilibrated with
50mM Hepes pH 7.0, 0.2M NaCl, lmM PMSF, O.lmM DTT,
0.01% CHAPS. Purified I10X protein was loaded with bovine
serum albumin and bovine carbonic anhydrase (Sigma, gel
filtration standards) as controls. Eluted proteins were detected
by the uv monitor, by SDS gel electrophoresis and by gel
retardation experiments. Other experiments used only I10X and
BSA, and only the two standard proteins. Glycerol gradients
contained 10% to 30% glycerol in 50mM Hepes pH 7.0, 0.2M
NaCl and were centnfuged in the Sorvall AH650 rotor at 40,000
rpm for 46 hours. Fractions (0.2ml) were collected from the top
of the tube and assayed by SDS gel electrophoresis, Western
blotting and gel retardation analysis. Gradients were loaded either
with II OX and BSA and carbonic anhydrase controls, or with
the two standards alone, and were run in parallel. The results
from these two approaches were used to derive the Stokes radius
and sedimentation coefficient of IIOX, and thus the true molecular
weight, using equations as described in reference 10.
RESULTS
Cloning and expression of the DNA binding domain of
Vmwl75 in a T7 expression vector, and its subsequent
purification
Gene IE-3, which encodes Vmwl75, lies in the repeats bounding
the short unique segment of the HSV-1 genome (Figure 1). A
combination of mutational and functional studies have shown that
the DNA binding domain of Vmwl75 lies within amino acid
residues approximately 276-490 (23, 25-30). This includes the
distal part of region 1 and the whole of region 2 of the polypeptide
(31).
The cloning of sections of the DNA binding domain of
Vmwl75 in a T7 expression vector has been presented before
(23). As described in the Methods section, plasmids pT7I9X,
pT7I10X and pT7Ill contain the coding regions of residues
252-523, 276-523 and 293-523 of Vmwl75 respectively. The
expressed polypeptides will be referred to as I9X, I10X and 111;
all were produced in amounts sufficient to be visible on SDS-
polyacrylamide gels stained with Coomassie Blue (Figure 2A).
s t i l l
i»x no nnx in NP M\v
I10X MW
IE-1 A\al probe
B
IE-3
-CD
IE-3
t I I It It
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Figure 1. The structure of the HSV-1 genome with the repeat sequences shown
as boxes and the positions of the two copies of gene IE-3 marked. Below is an
expansion of the IE-3 region with some of the landmark restriction sites; E =
EcoRl, B = BamHI, S «= Sstl, H = HincII, 'a' indicates the 'a' sequence which
divides the long and short repeats. The location of the IE-3 transcript is also
indicated, with the 1298 arrrino acid coding region shown below. Conserved region
2 of the polypeptide (codons 315-484) is also marked.
Figure 2. A. Expression of the Vmw 175 DNA binding domains in E. coli. Bacteria
were grown, expression from the T7 plasmids induced and crude extracts were
prepared by ammonium sulphate precipitation as detailed in Methods. The extracts
were analysed on a 12.5% SDS-polyacrylamide gel. The amount of each extract
loaded corresponded to that produced from about 3ml of induced bacterial culture.
I9X, 110, I10X and 111 indicate extracts prepared from bacteria harbouring
pT7I9X, pT7I10, pT7I10X and pT7Ill respectively. (pT7I10 is the parent of
pT7110X without the Xbal stop codon linker at the end of the expressed coding
region). NP is an extract prepared from induced bacteria which did not carry
an expression plasmid. MW indicates the molecular weight standards: BSA, 66kd;
egg albumin, 45kd; glyceraldehyde 3 phosphate dehydrogenase, 36kd; carbonic
anhydrase, 29kd; trypsinogen, 24kd; trypsin inhibitor, 20.1kd. The 110, I10X
and 111 proteins can be seen migrating close to carbonic anhydrase, as indicated
by the arrow. The I9X protein is marked by a dot. B. Gel retardation experiments
using partially purified non-fusion expression proteins. Suitable volumes of extracts
were incubated with the IE-1 Aval probe and the resultant complexes analysed
by gel electrophoresis. The position of the uncomplexed probe is shown by the
track on the right; the slower migrating DNA-protein complexes which are specific
to the non-fusion expression proteins are obvious. C. Purification of protein I10X.
A sample of the final purified product is shown next to molecular weight markers
(the additional marker band visible on this gel is lactalbumin, 14.2kd). The marker
track was at the edge of the gel, which ran slightly more slowly than tracks in
the middle, which explains the apparent slightly higher than expected mobility
of the I10X protein.
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To check that these expressed proteins were biologically active,
the extracts were used in gel retardation assays. The probe was
an Aval fragment from the IE-1 promoter which includes a strong
Vmwl75 binding site. Figure 2B confirms that extracts
containing I9X and II OX produced DNA-protein complexes
which were neither present in extracts containing 111 nor in
extracts from bacteria without an expression plasmid. The absence
of complexes formed by protein 111 confirms earlier observations
(23,30) that truncation of Vmwl75 at residue 293 removes
sequences important for DNA binding. Extracts with high binding
activity tended to produce additional multiple complex bands of
slower mobility which are most likely due to multiple protein
binding. It is not known whether this represents protein-protein,
or additional protein-DNA interactions. Confirmation of the
expression of active forms of the Vmwl75 DNA binding domain
in this system allowed the expansion of these studies to attempt
their purification.
IIS*
t ; 18
CA
1 24 CP 8
CA
111 13
BSA
116
.02 .01 .004 .002 MW
Figure 3. The IIOX protein is a dimer in solution. (A) 20/tg of BSA and 2<Vg
of carbonic anhydrase (CA) were loaded onto a Superose column with 10/ig of
purified I10X. Fractions (0.5ml) were collected and appropriate samples (based
on the uv scan) were analysed by SDS-gel electrophoresis; the positions of the
BSA and CA peaks are indicated. The same samples (fractions 11 to 24) were
analysed for active IIOX by a gel retardation experiment using the IE-3 probe.
The peak of I10X activity is shown in fraction 18. Track C contains a control
with approximately 20ng of purified I10X protein as a marker (the slower mobility
bands are discussed in the text). Lane P contains free probe. (B) 20/ig of BSA
and 20/ig of CA were loaded onto a 5ml 10—30% glycerol gradient with 10/ig
I10X. After centrifugation at 40k rpm for 46 hours, 0.2ml fractions were collected
and analysed by SDS gel electrophoresis and Western blotting (using a rabbit
antisenim generated by immunisation with purified I10X protein). The results
with fractions 8 to 21 are shown here; the positions of the peaks of BSA and
CA on a parallel stained gel are shown in fractions 16 and 11 respectively. The
I10X peak is in fraction 13. The control lane C contains unpurified I10X protein
from a crude bacterial extract. C. Glutaraldehyde cross linking of protein I10X.
The protein was treated with 0.02, 0.01, 0.004 and 0.002% glutaraldehyde (as
indicated) at room temperature for 2 hours and then analysed on an acrylamide
gel. The positions of monomer and cross-linked dimer proteins are marked.
Molecular weight standards are as in Figure 2.
We have purified to apparent homogeneity protein I10X. The
procedures used are described in detail in the Methods section;
Figure 2C shows a Coomassie blue stained gel of the final
preparation.
The purified Vmwl75 DNA binding domain is a dimer in
solution
Native, intact Vmwl75 is a dimer (10,35). Given that many DNA
binding proteins bind to DNA as dimers, it was of interest to
determine whedier the dimerisation of Vmwl75 was an intrinsic
property of the DNA binding domain itself.
A Pharmacia FPLC Superose 12 column was equilibrated with
a suitable buffer (see Methods) and then used to calculate the Stokes
radius of protein I10X, using bovine serum albumin and bovine
carbonic anhydrase as controls (Stokes radii 3.55nM and 2.28nM
respectively). The elution volumes of the three proteins were
determined by uv detection, SDS gel electrophoreis (data not
shown) and gel retardation experiments (Figure 3A). The II OX
protein eluted as a shoulder of the BSA peak, and its Stokes radius
was calculated as 3.0nM. Glycerol gradient centrifugation of the
same three proteins was used to determine the sedimentation
coefficient of I10X; BSA and carbonic anhydrase are 4.3S and
3.2S respectively. Comparison of sedimentation rates allowed the
calculation of the sedimentation coefficient of IIOX as 3.7S
(Figure 3B). The Stokes radius of I10X was then used to determine
its diffusion coefficient, which was then used to calculate the real
molecular weight of I10X; this was found to be 48kd, close to
the predicted dimeric molecular weight of 52kd.
In confirmation of these experiments, purified I10X protein
was treated with increasing concentrations of the cross-linking
agent glutaraldehyde, and the products analysed by gel
electrophoresis. The results (Figure 3Q showed clear formation
of I10X dimers. It is not known why the cross-linking was not
100% efficient. It was not apparendy a consequence of the I10X
molecules being in an equilibrium of dimers and monomers since
gel filtration analysis of cross-linked material showed that the
cross-linked dimers and the remaining un-linked protein eluted
as a single peak at the position expected of a uniform preparation
of dimers (data not shown).
The conclusion from these experiments is that II OX is a dimer
in solution, and that die ability of Vmwl75 to dimerise is most
probably a consequence of a dimerisation surface within the DNA
binding domain. Whether dimerisation is essential for DNA
binding is not currently known. It is intriguing that the DNA
binding site recognised by Vmwl75 is bi-partite (see below),
although die two parts have little in common. It should also be
noted that I10X forms multiple complexes on a probe molecule,
especially when present in large amounts (Figure 4A). If the
highest mobility complex contains one dimer of I10X, then diose
further up the gel probably represent multiples of the basic dimer,
either containing additional dimers which are recognising other
sites within the probe molecule or the result of further protein-
protein interactions.
Extensive mutagenesis of the Vmwl75 binding site at the cap
site of the IE-3 promoter reveals a functional bi-partite
structure
Previous analyses of the sequence requirements of Vmwl75
binding sites have shown that a proportion of these sites contain
the consensus ATCGTC, that diis sequence alone is insufficient
for binding, that alterations in some but not all of the bases in
the consensus disrupt binding and that a sequence further 3' is
 at U
niversity of G
lasgow
 on D
ecem
ber 19, 2012
http://nar.oxfordjournals.org/
D
ow
nloaded from
 
Nucleic Acids Research, Vol. 19, No. 18 4905
also required (17,20,23,27, 37,39). The directed mutagenesis
strategy of these studies suffers from the limitation that the
importance of nucleotides outside the conserved sequence could
be overlooked, and the effect of alternative substitutions has not
generally been investigated. The theoretical recognition of
consensus sequences, although very useful, is limited because
the theoretical predictions should be confirmed experimentally.
In order to expand upon the previous studies, we have used a
random mutagenesis method to create a family of Vmw 175
AGGACGCCCCGATCGTCCACACGGAGCGCG
I9X binding promt
AGGACGCCCCGATCGTCCACACGGAGCGCG
11 OX binding profll*
AGGACGCCCCGATCGTCCACACGGAGCGCG
Figure 4. The effect of point mutations in the IE-3 cap site probe on the binding
efficiency of Vmw 175 and the I9X and IlOX proteins. The sequence in the region
of the Vmwl75 binding site is shown in large type at the bottom of each panel.
The vertical bars above each base represent the percentage efficiency of binding
(as indicated on the right, compared to the wild type probe), of the relevant protein
when that base was mutated to the base shown in smaller type below. In most
instances the indicated change was the only one in the entire probe fragment.
The family of mutant probes was used to analyse binding by Vmwl75, I9X and
IlOX as indicated. These histograms represent a partial abstraction of the
information in Table 1.
binding site mutations with single point mutations at each position
in the consensus and its near environment.
The site chosen for study was that at the cap site of the IE-3
promoter (19) which has been shown to have a role in the
autoregulation of the IE-3 promoter, at least in transfection assays
(20). An oligonucleotide encompassing the region from —18 to
+ 17 was synthesised using nucleotide precursor reservoirs which
had been contaminated with low levels of each of the other
precursors. The resultant randomly mutated oligonucleotide was
then used as a primer for an M13 mutagenesis reaction using
the EcoRI-BamHI (-108 to +27) IE-3 fragment as template.
The progeny M13 phage were screened by DNA sequence
analysis. Examination of 400 plaques produced 100 useful
mutants which had substitution or deletion mutations in the region
of the consensus. In particular, point mutations were isolated in
all bases over a 30 nucleotide stretch starting 11 bases 5' of the
A of the ATCGTC motif; at 20 of these positions alternative
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The wild type sequence of the IE-3 capsite region is shown vertically on the left.
The binding efficiency of intact Vmw 175 (17 + ) and the I9X and 11 OX proteins
to the mutant probes is shown as a percentage of wild type. A slash indicates
that the mutation was not isolated, NT = isolated but not tested, X = the wild
type base. The numbers given for bases encompassing the core region GAT-
CGTCCACACGG are mostly the averages of at least two separate determinations.
The nature of the mutation is shown across the top row (replacement of the usual
base with A, C, G or T as indicated); D represents a single base deletion. All
mutations are single base changes except where indicated by a superscript a; in
these cases the probe contains two point mutations. The results with double
mutations have been included only where any reduction can be attributed
unambiguously to the position where the result is shown in the Table. This was
possible in those instances where a single change at the other position (not indicated
on the Table), in an independent mutant, produced no reduction in binding.
Ambiguous double mutants have not been included in this Table.
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substitutions were also found, while in 8 cases all possible base
substitutions were isolated. In addition, 10 single base deletions
in the region of the consensus were discovered. These mutations
allowed a rigorous examination of the DNA sequence
requirements for binding by Vmwl75 at this site.
Radiolabelled probes were prepared from all the mutant Ml3
templates by the prime-cut method (38). A reference wild type
probe was included in each batch of probes synthesised as a
control; because of the procedure used the concentrations and
specific activities of all probes in a batch could be made identical,
thus allowing a true comparison of relative binding affinities. The
probes were used in gel retardation experiments using HSV-1
infected nuclear extracts; the results of several hundred individual
incubation reactions are summarised in Figure 4 and Table 1 and
the accompanying footnotes. Considering binding by intact
Vmwl75 in crude nuclear extracts, the mutations can be classified
as follows:
(a) Positions at which all mutations which have little or no effect
on binding efficiency. While the results of the gel retardation
experiments were in general reproducible, the intrinsic errors
involved in scanning the gels and other experimental
manipulations means that, for the purposes of this analysis, this
group of positions is taken to include all those which bind at the
level of 50% or better. Mutations falling into this class include
all those in bases more than one base 5' of the A of ATCGTC,
the last C of ATCGTC and the next 4 nucleotides, and all
positions 3' of the distal part of the consensus (CGG). The lack
of importance of the last C of the ATCGTC of the IE-3 site is
consistent with an identical observation with gD site II (23).
(b) Positions at which some but not all base substitutions are
at least partially tolerated. Alteration of the second T of AT-
CGTC to an A resulted in a reduction to 30% normal binding,
while changes to C or G reduced binding to less than 10%.
Similarly, alteration of the C of the distal CGG part of the
consensus to a T had virtually no effect, while a change to an
A gave a drastic reduction. Thus a pyrimidine is sufficient at
this position. Alteration of the first G of CGG to a C was also
partially tolerated, in keeping with the existence of a C at this
position in the gD site II (23).
(c) Positions at which all available alterations reduced binding.
This could could be sub-divided into those in which mutations
reduced binding to below 10% of normal (the first T and the
G of ATCGTC) and those which appeared important but less
crucial (the A and first C of ATCGTC, and the second G of
CGG). It should be noted that not one of the single point mutations
resulted in complete elimination of Vmwl75 binding; extended
exposure of the autoradiograms always revealed a low level of
complex formation (data not shown).
(d) Positions at which base substitutions increase the efficiency
of binding. The only candidate for this effect is the G immediately
5' of the A of ATCGTC; alteration of this to a pyrimidine gave
binding efficiencies of between 150 and 200%. This observation
is consistent with the fact that deletion of this G (thus effectively
replacing it with a C) also result in binding at about 150% of
wild type.
(e) The effect of single base deletions. Single base deletions at
several locations in the mutated region were isolated (Table 1).
Those 5' or 3' of the consensus region had little effect, except
that removing the G 5' to the A of ATCGTC which, as noted
above, resulted in an increase in binding efficiency. Deletion of
the first T of ATCGTC gave the most severe reduction in binding
efficiency of all mutations isolated, with a specific complex barely
visible even after prolonged exposure of the gel. Other deletions
in the proximal and distal parts of the consensus also reduced
binding by at least 90%. These severe effects can be explained
by an additional requirement for a precise spacing between the
proximal and distal portions, since deletion of two separate single
bases in the 5 nucleotide spacer (in which no point mutations
had an effect) resulted in low binding efficiencies.
Therefore this analysis clearly shows that IE-3 Vmwl75
binding site consists of a proximal and a distal portion, that (at
least for the intact protein) the distance between the two parts
is important, and that there are some relatively crucial bases
within these motifs. However, there is sufficient flexibility in
the binding sequence such that sequences apparently quite
divergent from the consensus could bind Vmwl75. In summary,
the IE-3 Vmwl75 binding site can be written as ATcGtnnnnnYgG
where lower case letters depict bases where at least some
alterations retain more than 15% binding. This is very similar
to the previously published consensus sequences, but it has been
arrived at after extensive experimental testing.
The bacterially expressed Vmwl75 DNA binding domain
proteins exhibit some relaxation of binding speciflcty
Binding of the I9X and II OX proteins to the family of mutant
probes was also analysed. Overall, the results obtained were
similar to those with intact Vmwl75 (Figure 4) but with some
notable differences. Firstly, the strict requirement of Vmwl75
for precise spacing between the two parts of the consensus was
not observed with either I9X or IIOX (Table 1). Secondly,
replacement of the C of CGG with an A had only a moderate
effect on binding of both I9X and I10X. Thirdly, replacement
of the second T of ATCGTC by any base had only moderate
effects on binding by I10X (I9X gave results intermediate between
I10X and whole Vmwl75 with these mutations). Thus, consistent
with earlier results (23,30), the binding specificities of the
bacterially expressed proteins are very similar to those of the
whole protein, but there is some relaxation of specificity. The
lack of requirement for precise spacing of the two parts of the
consensus suggests that the isolated DNA binding domain may
be more flexible than the intact protein; this suggests that other
parts of Vmwl75 might, in principle, be able to influence the
DNA binding activity of the intact protein (40).
DISCUSSION
This paper describes the expression and purification of the DNA
binding domain of the major transcriptional regulator of HSV-1
and the characterisation of its binding site. It is of interest to
discuss the results in terms of the nature of the DNA binding
domain itself and of its target sequence, how the results with the
isolated sub-fragment of the protein relate to those with the whole
protein, and how DNA binding in general relates to the function
of Vmwl75.
Although the DNA binding domain of Vmwl75 has been
expressed as a fusion protein in bacteria in previous studies (30),
the non-fusion proteins described in this paper have some distinct
advantages. Firstly, they can be purified in milligram amounts,
which opens the possibilities of future structural studies.
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Secondly, that they can be expressed as stable proteins suggests
that they represent a separable functional domain of the protein.
It is probably relevant that incorporation into the expression vector
of sequences progressing further towards the C-terminus of
Vmwl75 results in the synthesis of unstable polypeptides which
are readily degraded (during subsequent purification) to peptides
of very similar size to I9X and I10X (results not shown). That
I9X and II OX are relatively stable is consistent with the release
by proteolysis of the DNA binding domain of Vmwl75 (29) in
a fragment slightly smaller than I10X (results not shown).
The study of the DNA sequence requirements for Vmwl75
binding described here is the most thorough examination of this
subject to date. The results show, perhaps not surprisingly, the
importance of most of the bases identified in previous consensus
sequences derived from known binding sites. However, this study
convincingly demonstrates the requirement for both proximal and
distal parts of the consensus and that, although the region
protected from DNAase I digestion extends several bases 5' and
3' from the consensus (13), bases outside the conserved region
have little or no sequence-specific contribution to Vmwl75
binding. This analysis is also consistent with the results of
methylation interference experiments which identified important
bases within both proximal and distal parts of the consensus (19).
We have also shown that the bases within the consensus are not
equal in their contribution to binding affinity, and that no single
base is absolutely required. The implication is that, within a
binding affinity covering approximately an order of magnitude,
that the binding specificity of Vmwl75 is quite relaxed. This is
consistent with the conclusions of a recent study (24) which
suggested, on the basis of a statistical comparison of known
Vmwl75 binding sites, that sites could occur at frequent locations
throughout the HSV-1 genome. It would have been possible to
have continued to isolate mutations until all possible single base
changes had been found. However, given the flexibility in
binding, more information might be obtained by using methods
which would detect all possible sequences (including those not
obviously related to the IE-3 cap site) that are actually bound
by Vmwl75.
The slight relaxation of binding specificity observed with the
non-fusion proteins compared to the intact protein, including the
loss of a requirement for exact spacing between the proximal
and distal parts of the consensus, suggests some interesting
possibilities. Indeed, the relaxation of binding specificity is even
more pronounced with the proteinase K resistant domain of
Vmwl75. This exhibits a similar binding specificity to the whole
protein when wild type and mutant oligonucleotide probes are
used, but when such mutants are incorporated into a larger probe
fragment, binding after PK treatment becomes less specific (data
not shown). If Vmwl75 were normally to undergo proteolysis
in the infected cell, it seems likely that the DNA binding domain
might remain as a relatively stable entity which could then bind
to a variety of sites throughout the genome. This could have a
role in the replicative cycle of the virus.
Lastly, it is pertinent to discuss the role of DNA binding in
Vmwl75 function. While much early work stressed the
correlation of mutations which affected DNA binding with defects
in transactivation and repression by Vmwl75 (25,28) some recent
results suggest that the situation is not quite so simple. In
particular, the ability of Vmwl75 to bind to the 'non-consensus'
sites upstream of the tk promoter is dispensible for tk promoter
activation during infection (22), and deletion from the viral
genome of three binding sites in the vicinity of the gD promoter
has no affect on the levels of gD expression during infection
(manuscript in preparation). It is possible to reconcile these results
by suggesting that Vmwl75 acts as a trans-acting enhancer, such
that binding to any one of the potentially large number of binding
sites in the coding or regulatory regions of a gene would enable
its function. Thus lack of binding at any one site would not be
detrimental. However, a virus has been isolated which grows
normally in tissue culture yet contains two mutations in DNA
binding domain of Vmwl75 which greatly reduce its ability to
bind to DNA (41). While this result seems to suggest strongly
that DNA binding by Vmwl75 is not obligately connected to its
function, it does not explain why the DNA binding domain of
Vmwl75 is so highly conserved in all related proteins (31-34)
and why so many of the mutations which affect DNA binding
also disrupt function. Clarification of this point, and definition
of the functions of the DNA binding domain of Vmwl75, requires
a thorough mutagenic study of the domain itself. This work is
in progress.
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